Dimensional Fund Advisors
ORIC icon

Dimensional Fund Advisors’s Oric Pharmaceuticals ORIC Stock Holding History

Dimensional Fund Advisors’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.6M Buy
1,471,290
+244,060
+20% +$2.77M ﹤0.01% 2008
2025
Q4 		$10M Buy
1,227,230
+433,359
+55% +$4.99M ﹤0.01% 2282
2025
Q3 		$9.52M Buy
793,871
+79,005
+11% +$831K ﹤0.01% 2320
2025
Q2 		$7.26M Sell
714,866
-12,964
-2% -$87K ﹤0.01% 2407
2025
Q1 		$4.06M Buy
727,830
+10,642
+1% +$93.1K ﹤0.01% 2555
2024
Q4 		$5.79M Buy
717,188
+103,237
+17% +$947K ﹤0.01% 2494
2024
Q3 		$6.29M Buy
613,951
+147,289
+32% +$1.46M ﹤0.01% 2454
2024
Q2 		$3.3M Buy
466,662
+305,860
+190% +$2.74M ﹤0.01% 2620
2024
Q1 		$2.21M Buy
160,802
+136,126
+552% +$1.62M ﹤0.01% 2771
2023
Q4 		$227K Sell
24,676
-16
-0.1% -$116 ﹤0.01% 3178
2023
Q3 		$149K Buy
24,692
+16
+0.1% +$131 ﹤0.01% 3259
2023
Q2 		$191K Buy
24,676
+14,632
+146% +$83.1K ﹤0.01% 3243
2023
Q1 		$57.3K Buy
+10,044
New +$52.5K ﹤0.01% 3372

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return